Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2324]
News [5462]
Articles [134]
Editorials [4]
Conferences [158]
elearning [13]
Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475...
Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston...
Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )
1 May 2014
Promising research on the use of palbociclib in the treatment of breast cancer
Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Promising research on the use of palbociclib in the treatment of breast cancer ( Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
1 May 2014
Role of genomics in assessing risk, especially in ovarian cancer
Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA
Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )
1 May 2014
Targeted Anti-cancer Therapies (TAT) conference roundup
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Targeted Anti-cancer Therapies (TAT) conference roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Apr 2014
I-SPY 2 trial shows promising development for some breast cancer patients using...
Dr John W. Park - University of California, San Francisco Hellen Diller Family...
I-SPY 2 trial shows promising development for some breast cancer patients using neratinib ( Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA )
16 Apr 2014
Genetic testing can improve selection of women with ER positive breast cancer...
Prof Mitch Dowsett - The Institute of Cancer Research, London, UK
Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy ( Prof Mitch Dowsett - The Institute of Cancer Research, London, UK )
1 Apr 2014
EBCC 2014 key messages to doctors
Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
EBCC 2014 key messages to doctors ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014
Ganetespib in first-line treatment of women with metastatic HER2 positive or...
Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014
The 1st Immunotherapy of Cancer Conference (ITOC)
Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche...
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer ( Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland )
24 Mar 2014
Mechanisms of action and robotics in mCRPC
Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China
Mechanisms of action and robotics in mCRPC ( Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China )
21 Mar 2014
mCRPC management in Taiwan - expert interview
Prof Paul de Souza and Dr Wayne Yen-Hwa Chang
mCRPC management in Taiwan - expert interview ( Prof Paul de Souza and Dr Wayne Yen-Hwa Chang )
21 Mar 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation